ABIONYX Monthly Voting Rights Update

ABIONYX Pharma, listed on Euronext Paris Compartment C, has released its monthly update on total voting rights and shares. As of June 30, 2026, the company reports 42,568,071 shares outstanding. This corresponds to a total of 52,292,148 gross voting rights. Net voting rights stand at 52,017,701.

The gross number reflects all shares with voting rights, even those suspended, and is crucial for calculating threshold crossings under Article 223-11 of the AMF General Regulations. Meanwhile, the net figure accounts for shares eligible to vote at shareholder meetings, providing transparency as per AMF's 2007 recommendation.